Corvus Pharmaceuticals, Inc. (CRVS) vs Monte Rosa Therapeutics, Inc. (GLUE)
- Corvus Pharmaceuticals, Inc. CRVS 9.52 −3.35%
- Monte Rosa Therapeutics, Inc. GLUE 9.74 −3.75%
Corvus Pharmaceuticals, Inc. and Monte Rosa Therapeutics, Inc. are both Biotechnology companies. Corvus Pharmaceuticals, Inc. and Monte Rosa Therapeutics, Inc. are of similar size ($863.4M and $828.6M). Corvus Pharmaceuticals, Inc. has the higher net margin (0.00% vs −560.9%) and the lower return on invested capital (−352.5% vs 0.00%). Across the 13 metrics below, Corvus Pharmaceuticals, Inc. leads on 9 and Monte Rosa Therapeutics, Inc. on 4.
Valuation
Profitability
| Metric | CRVS | GLUE | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 100.00% | 65.16% |
| Operating margin | 0.00% | (633.04%) | 0.00% |
| Net margin | 0.00% | (560.85%) | 0.00% |
| Free cash flow margin | 0.00% | (111.66%) | 0.00% |
| Return on equity | (18.98%) | (42.66%) | (56.36%) |
| Return on assets | (17.64%) | (30.67%) | (48.04%) |
| Return on invested capital | (352.49%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack